MERIT, a global provider of clinical trial endpoint and technology services, has announced the acqui...

Outlook Therapeutics shared results from the NORSE EIGHT clinical trial at the Hawaiian Eye and Reti...

Arctic Vision has received regulatory approval for ARCATUS (triamcinolone acetonide 4 mg/0.1 mL inje...

Stuart Therapeutics has announced the successful completion of its Phase 3 clinical trial for ST-100...

Pantheon Vision has announced the successful completion of its third meeting with the FDA review tea...

Nacuity Pharmaceuticals has announced that the FDA has granted Fast Track Designation to its investi...

HelpMeSee has announced new partnerships with the University of Southern California (USC)/LA General...

Glaukos has shared several promising clinical updates for its iDose sustained-release procedural pha...

Formycon, in collaboration with its licensing partner Klinge Biopharma, has announced that the Europ...

RhyGaze, a biotechnology company with headquarters in Basel, Switzerland, and Philadelphia, PA, has ...